| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = -$45,358 ) |
| | 2024 | 2023 | THE CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY | 1000 BLYTHE BLVD | CHARLOTTE | NC | 28203-5812 | MECKLENBURG | USA | H79TI086054 | Atrium Health Emergency Medicine Service Line Pain and Addiction Care Improvement | 000 | 1 | SAMHSA | 11/14/2023 | $0 |
| | 2024 | 2021 | THE CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY | 1000 BLYTHE BLVD | CHARLOTTE | NC | 28203-5812 | MECKLENBURG | USA | R21LM013373 | Classifying Sepsis Survivors into Actionable Phenotypes | 000 | 2 | NIH | 11/17/2023 | -$45,358 |
|
| Issue Date FY: 2023 ( Subtotal = $2,584,537 ) |
| | 2023 | 2023 | CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY, THE | 1000 BLYTHE BOULEVARD | CHARLOTTE | NC | 28203-5812 | MECKLENBURG | USA | H4B15603 | Poison Control Stabilization and Enhancement Program | 01 | 15 | HRSA | 8/8/2023 | $0 |
| | 2023 | 2023 | CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY, THE | 1000 BLYTHE BOULEVARD | CHARLOTTE | NC | 28203-5812 | MECKLENBURG | USA | R01NR018434 | A Sepsis Transition Program to Reduce Morbidity and Mortality in High Risk Individuals | 000 | 5 | NIH | 4/6/2023 | $562,398 |
| | 2023 | 2023 | CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY, THE | 1000 BLYTHE BOULEVARD | CHARLOTTE | NC | 28203-5812 | MECKLENBURG | USA | R01NR018434 | A Sepsis Transition Program to Reduce Morbidity and Mortality in High Risk Individuals | 001 | 5 | NIH | 5/1/2023 | -$562,398 |
| | 2023 | 2023 | CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY, THE | 1000 BLYTHE BOULEVARD | CHARLOTTE | NC | 28203-5812 | MECKLENBURG | USA | H79TI086054 | Atrium Health Emergency Medicine Service Line Pain and Addiction Care Improvement | 000 | 1 | SAMHSA | 7/6/2023 | $476,492 |
| | 2023 | 2023 | Charlotte-Mecklenburg Hospital Authority, The | 1000 Blythe Boulevard | Charlotte | NC | 28203-5812 | MECKLENBURG | USA | HITEP220055 | Comprehensive Trauma Training of United States Special Operations Command's Austere Resuscitative Surgical Teams Through Military-Civilian Partnerships at Atrium Health's Carolina Medical Center | 00 | 2 | ASPR | 9/26/2023 | $215,000 |
| | 2023 | 2023 | CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY, THE | 1000 BLYTHE BOULEVARD | CHARLOTTE | NC | 28203-5812 | MECKLENBURG | USA | UH3DE031250 | Randomized Trial of non-Surgical Therapy and Oral Hygiene Instruction to Reduce Risk of Infective Endocarditis | 002 | 2 | NIH | 7/18/2023 | $0 |
| | 2023 | 2023 | THE CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY | 1000 BLYTHE BLVD | CHARLOTTE | NC | 28203-5812 | MECKLENBURG | USA | UH3DE031250 | Randomized Trial of non-Surgical Therapy and Oral Hygiene Instruction to Reduce Risk of Infective Endocarditis | 001 | 2 | NIH | 6/1/2023 | $105,046 |
| | 2023 | 2023 | CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY, THE | 1000 BLYTHE BOULEVARD | CHARLOTTE | NC | 28203-5812 | MECKLENBURG | USA | UH3DE031250 | Randomized Trial of non-Surgical Therapy and Oral Hygiene Instruction to Reduce Risk of Infective Endocarditis | 000 | 2 | NIH | 2/14/2023 | $1,179,697 |
| | 2023 | 2023 | CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY, THE | 1000 Blythe Boulevard | Charlotte | NC | 28203-5812 | MECKLENBURG | USA | H4B15603 | Poison Control Stabilization and Enhancement Program | 00 | 15 | HRSA | 8/3/2023 | $713,348 |
| | 2023 | 2022 | THE CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY | 1000 BLYTHE BLVD | CHARLOTTE | NC | 28203-5812 | MECKLENBURG | USA | UG3DE031250 | Randomized Trial of non-Surgical Therapy and Oral Hygiene Instruction to Reduce Risk of Infective Endocarditis | 000 | 1 | NIH | 6/1/2023 | -$105,046 |
| | 2023 | 2022 | CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY, THE | 1000 BLYTHE BOULEVARD | CHARLOTTE | NC | 28203-5812 | MECKLENBURG | USA | H4B15603 | Poison Control Stabilization and Enhancement Program | 01 | 14 | HRSA | 11/17/2022 | $0 |
| | 2023 | 2022 | CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY, THE | 1000 BLYTHE BOULEVARD | CHARLOTTE | NC | 28203-5812 | MECKLENBURG | USA | R01CA172513 | Role of PTEN and PI-3 Kinase in Medulloblastomagenesis | 002 | 5 | NIH | 5/15/2023 | $0 |
| | 2023 | 2022 | CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY, THE | 1000 BLYTHE BOULEVARD | CHARLOTTE | NC | 28203-5812 | MECKLENBURG | USA | R01CA172513 | Role of PTEN and PI-3 Kinase in Medulloblastomagenesis | 001 | 5 | NIH | 3/10/2023 | $0 |
| | 2023 | 2022 | CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY, THE | 1000 BLYTHE BOULEVARD | CHARLOTTE | NC | 28203-5812 | MECKLENBURG | USA | R01CA215651 | Dual PI3K/BRD4 Inhibitory Chemotype for Maximum Inhibition of MYC and Cancer | 000 | 5 | NIH | 7/27/2023 | $0 |
| | 2023 | 2022 | Charlotte-Mecklenburg Hospital Authority, The | 1000 Blythe Boulevard | Charlotte | NC | 28203-5812 | MECKLENBURG | USA | HITEP220055 | Comprehensive Trauma Training of United States Special Operations Command's Austere Resuscitative Surgical Teams Through Military-Civilian Partnerships at Atrium Health's Carolina Medical Center | 01 | 1 | ASPR | 2/9/2023 | $0 |
| | 2023 | 2022 | CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY, THE | 1000 BLYTHE BOULEVARD | CHARLOTTE | NC | 28203-5812 | MECKLENBURG | USA | H4B15603 | Poison Control Stabilization and Enhancement Program | 02 | 14 | HRSA | 2/6/2023 | $0 |
| | 2023 | 2022 | Charlotte-Mecklenburg Hospital Authority, The | 1000 Blythe Boulevard | Charlotte | NC | 28203-5812 | MECKLENBURG | USA | CPIMP211306 | Increasing Clinical Trial Awareness in Minority Systemic Lupus Erythematosus Patients While Decreasing Barriers to Care | 01 | 2 | DHHS/OS | 9/29/2023 | $0 |
| | 2023 | 2021 | THE CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY | 1000 BLYTHE BLVD | CHARLOTTE | NC | 28203-5812 | MECKLENBURG | USA | U01DE022939 | Long-term Oral Complications of an Established Head and Neck Cancer Cohort- Clinical Registry of Dental Outcomes in Head and Neck Cancer Patients: OraRad | 002 | 9 | NIH | 11/10/2022 | $801,407 |
| | 2023 | 2021 | Charlotte-Mecklenburg Hospital Authority, The | 1000 Blythe Boulevard | Charlotte | NC | 28203-5812 | MECKLENBURG | USA | CPIMP211306 | Increasing Clinical Trial Awareness in Minority Systemic Lupus Erythematosus Patients While Decreasing Barriers to Care | 01 | 2 | DHHS/OS | 9/29/2023 | $0 |
| | 2023 | 2020 | THE CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY | 1000 BLYTHE BLVD | CHARLOTTE | NC | 28203-5812 | MECKLENBURG | USA | U01DE022939 | Long-term Oral Complications of an Established Head and Neck Cancer Cohort- Clinical Registry of Dental Outcomes in Head and Neck Cancer Patients: OraRad | 001 | 8 | NIH | 11/10/2022 | -$443,665 |
| | 2023 | 2020 | CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY, THE | 1000 Blythe Boulevard | Charlotte | NC | 28203-5812 | MECKLENBURG | USA | R01CE003001 | Implementing a Multimodal Path to RecOVEry (IMPROVE): Primary and Secondary Prevention of Opioid Overdose in Acute Care | 02 | 3 | CDC | 1/4/2023 | $0 |
| | 2023 | 2019 | CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY, THE | 1000 Blythe Boulevard | Charlotte | NC | 28203-5812 | MECKLENBURG | USA | R01CE003001 | Implementing a Multimodal Path to RecOVEry (IMPROVE): Primary and Secondary Prevention of Opioid Overdose in Acute Care | 02 | 3 | CDC | 1/4/2023 | $0 |
| | 2023 | 2019 | THE CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY | 1000 BLYTHE BLVD | CHARLOTTE | NC | 28203-5812 | MECKLENBURG | USA | R21AA025429 | Role of Exosomal microRNAs in Alcohol-induced Liver Injury | 000 | 2 | NIH | 11/21/2022 | $0 |
| | 2023 | 2019 | CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY, THE | 1000 BLYTHE BOULEVARD | CHARLOTTE | NC | 28203-5812 | MECKLENBURG | USA | R01CA172513 | Role of PTEN and PI-3 Kinase in Medulloblastomagenesis | 000 | 4 | NIH | 3/10/2023 | $0 |
| | 2023 | 2019 | THE CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY | 1000 BLYTHE BLVD | CHARLOTTE | NC | 28203-5812 | MECKLENBURG | USA | U01DE022939 | Long-term Oral Complications of an Established Head and Neck Cancer Cohort- Clinical Registry of Dental Outcomes in Head and Neck Cancer Patients: OraRad | 000 | 7 | NIH | 11/10/2022 | -$357,742 |
| | 2023 | 2018 | CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY, THE | 1000 Blythe Boulevard | Charlotte | NC | 28203-5812 | MECKLENBURG | USA | R01CE003001 | Implementing a Multimodal Path to RecOVEry (IMPROVE): Primary and Secondary Prevention of Opioid Overdose in Acute Care | 02 | 3 | CDC | 1/4/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $5,494,266 ) (Continued on the next page) |
| | 2022 | 2022 | CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY, THE | 1000 BLYTHE BOULEVARD | CHARLOTTE | NC | 28203-5812 | MECKLENBURG | USA | R01HL151854 | Primary care Implementation and evaluation of Coach McLungs? an asthma shared decision-making intervention, across a large healthcare system | 000 | 2 | NIH | 7/26/2022 | $715,948 |
| | 2022 | 2022 | CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY, THE | 1000 Blythe Boulevard | Charlotte | NC | 28203-5812 | MECKLENBURG | USA | HITEP220055 | Comprehensive Trauma Training of United States Special Operations Command's Austere Resuscitative Surgical Teams Through Military-Civilian Partnerships at Atrium Health's Carolina Medical Center | 00 | 1 | ASPR | 9/29/2022 | $80,000 |
| | 2022 | 2022 | CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY, THE | 1000 BLYTHE BOULEVARD | CHARLOTTE | NC | 28203-5812 | MECKLENBURG | USA | R01CA172513 | Role of PTEN and PI-3 Kinase in Medulloblastomagenesis | 001 | 5 | NIH | 8/10/2022 | $309,307 |
| | 2022 | 2022 | CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY, THE | 1000 BLYTHE BOULEVARD | CHARLOTTE | NC | 28203-5812 | MECKLENBURG | USA | R01CA215651 | Dual PI3K/BRD4 Inhibitory Chemotype for Maximum Inhibition of MYC and Cancer | 000 | 5 | NIH | 7/27/2022 | $457,586 |
| | 2022 | 2022 | CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY, THE | 1000 BLYTHE BOULEVARD | CHARLOTTE | NC | 28203-5812 | MECKLENBURG | USA | R01NR018434 | A Sepsis Transition Program to Reduce Morbidity and Mortality in High Risk Individuals | 001 | 4 | NIH | 5/13/2022 | $146,310 |
| | 2022 | 2022 | CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY, THE | 1000 BLYTHE BOULEVARD | CHARLOTTE | NC | 28203-5812 | MECKLENBURG | USA | R01NR018434 | A Sepsis Transition Program to Reduce Morbidity and Mortality in High Risk Individuals | 000 | 4 | NIH | 5/12/2022 | $620,012 |
| | 2022 | 2022 | CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY, THE | 1000 Blythe Boulevard | Charlotte | NC | 28203-5812 | MECKLENBURG | USA | CPIMP211306 | Increasing Clinical Trial Awareness in Minority Systemic Lupus Erythematosus Patients While Decreasing Barriers to Care | 00 | 2 | DHHS/OS | 9/14/2022 | $257,970 |
| | 2022 | 2022 | CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY, THE | 1000 BLYTHE BOULEVARD | CHARLOTTE | NC | 28203-5812 | MECKLENBURG | USA | UG3DE031250 | Randomized Trial of non-Surgical Therapy and Oral Hygiene Instruction to Reduce Risk of Infective Endocarditis | 001 | 1 | NIH | 3/21/2022 | $0 |
| | 2022 | 2022 | CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY, THE | 1000 BLYTHE BOULEVARD | CHARLOTTE | NC | 28203-5812 | MECKLENBURG | USA | UG3DE031250 | Randomized Trial of non-Surgical Therapy and Oral Hygiene Instruction to Reduce Risk of Infective Endocarditis | 000 | 1 | NIH | 1/28/2022 | $660,849 |
| | 2022 | 2022 | CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY, THE | 1000 BLYTHE BOULEVARD | CHARLOTTE | NC | 28203-5812 | MECKLENBURG | USA | R21AA029241 | FABP4 Released from Steatotic Hepatocytes in Alcoholic Liver Disease Enhances Hepatic Tumor Progression | 000 | 2 | NIH | 8/12/2022 | $185,844 |
| | 2022 | 2022 | Charlotte-Mecklenburg Hospital Authority, The | 1000 Blythe Boulevard | Charlotte | NC | 28203-5812 | MECKLENBURG | USA | H4B15603 | Poison Control Stabilization and Enhancement Program | 00 | 14 | HRSA | 8/15/2022 | $688,867 |
| | 2022 | 2022 | CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY, THE | 1000 BLYTHE BOULEVARD | CHARLOTTE | NC | 28203-5812 | MECKLENBURG | USA | R21HS027248 | Personalized Clinical Decision Support to Improve Participation in Hospital at Home | 001 | 2 | AHRQ | 4/20/2022 | $101,781 |
| | 2022 | 2022 | CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY, THE | 1000 BLYTHE BOULEVARD | CHARLOTTE | NC | 28203-5812 | MECKLENBURG | USA | U01DE022939 | Long-term Oral Complications of an Established Head and Neck Cancer Cohort- Clinical Registry of Dental Outcomes in Head and Neck Cancer Patients: OraRad | 002 | 10 | NIH | 9/19/2022 | $0 |
| | 2022 | 2022 | CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY, THE | 1000 BLYTHE BOULEVARD | CHARLOTTE | NC | 28203-5812 | MECKLENBURG | USA | U01DE022939 | Long-term Oral Complications of an Established Head and Neck Cancer Cohort- Clinical Registry of Dental Outcomes in Head and Neck Cancer Patients: OraRad | 001 | 10 | NIH | 8/29/2022 | $1,409,114 |
| | 2022 | 2021 | CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY, THE | 1000 Blythe Boulevard | Charlotte | NC | 28203-5812 | MECKLENBURG | USA | CPIMP211306 | Increasing Clinical Trial Awareness in Minority Systemic Lupus Erythematosus Patients While Decreasing Barriers to Care | 00 | 2 | DHHS/OS | 9/14/2022 | $0 |
| | 2022 | 2021 | Charlotte-Mecklenburg Hospital Authority, The | 1000 Blythe Boulevard | Charlotte | NC | 28203-5812 | MECKLENBURG | USA | CPIMP211306 | Increasing Clinical Trial Awareness in Minority Systemic Lupus Erythematosus Patients While Decreasing Barriers to Care | 03 | 1 | DHHS/OS | 6/15/2022 | $0 |
| | 2022 | 2021 | Charlotte-Mecklenburg Hospital Authority, The | 1000 Blythe Boulevard | Charlotte | NC | 28203-5812 | MECKLENBURG | USA | CPIMP211306 | Increasing Clinical Trial Awareness in Minority Systemic Lupus Erythematosus Patients While Decreasing Barriers to Care | 02 | 1 | DHHS/OS | 1/24/2022 | $0 |
| | 2022 | 2021 | Charlotte-Mecklenburg Hospital Authority, The | 1000 Blythe Boulevard | Charlotte | NC | 28203-5812 | MECKLENBURG | USA | CPIMP211306 | Increasing Clinical Trial Awareness in Minority Systemic Lupus Erythematosus Patients While Decreasing Barriers to Care | 01 | 1 | DHHS/OS | 10/27/2021 | $0 |
| | 2022 | 2021 | CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY, THE | 1000 BLYTHE BOULEVARD | CHARLOTTE | NC | 28203-5812 | MECKLENBURG | USA | R21HS027248 | Personalized Clinical Decision Support to Improve Participation in Hospital at Home | 000 | 1 | AHRQ | 4/11/2022 | $0 |
|
